Hogan Lovells 2024 Election Impact and Congressional Outlook Report
The Hogan Lovells team represented LCMC throughout the process, guiding it through the initial application and approval process at the state level before successfully defending the transaction against the FTC challenge.
“We are proud to have helped LCMC Health defeat the FTC’s challenge in this matter,” added Ken Field, Head of Hogan Lovells’ Health Care Antitrust practice. “LCMC trusted us with this groundbreaking strategy to address local health needs and we look forward to working with other systems around the country to do the same.”
Hogan Lovells regularly counsels health systems on their strategic growth initiatives and represents clients in many different sectors in merger and other antitrust litigation. This case is Hogan Lovells’ third major antitrust litigation win in the life sciences sector in three years, following the successful US$13 billion UnitedHealth-Change Healthcare merger win against the U.S. Department of Justice in September 2022 and the defeat of the FTC’s challenge to Thomas Jefferson University’s merger with Albert Einstein Healthcare Network in March 2021.
In addition to Field, the Hogan Lovells litigation team includes partners Benjamin Holt and Sean Marotta and senior associate Christopher Fitzpatrick (all Washington, D.C.).